N V Hevér
Biographic Data
| ID | 6792257 |
|---|---|
| NAME | N V Hevér |
| GIVEN NAMES | N V |
| FAMILY NAME | Hevér |
| SIGNATURE | HEVÉR N V |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2013 |
| LATEST PUBLICATION YEAR | 2014 |
| H-INDEX | 0 |
Letters and debate
In a recently published article, Hever and Balogh ambitiously attempted to describe the “German approach to cost-effectiveness analysis in health care” (Hever – Balogh 2013). Unfortunately, parts of the text submitted by the authors contain inaccurate information by i) confusing the two separate “Methods” papers of IQWiG, ii) referring to the outdated aim of providing information for setting maximum reimbursable prices, and iii) erroneously stati…
The German approach to cost-effectiveness analysis in health care
Health technology assessment (HTA) is a dynamic, rapidly evolving process embracing different types of assessment that inform decisions about the value (i.e., benefits, risks and costs) of new and existing technologies. The role of HTA is to support health policy decision-making and financing in health care. In this paper we describe and analyse the German approach to cost-effectiveness analysis in health care and HTA. Two institutes operate as H…
No prominent works on this page.
The German approach to cost-effectiveness analysis in health care
Health technology assessment (HTA) is a dynamic, rapidly evolving process embracing different types of assessment that inform decisions about the value (i.e., benefits, risks and costs) of new and existing technologies. The role of HTA is to support health policy decision-making and financing in health care. In this paper we describe and analyse the German approach to cost-effectiveness analysis in health care and HTA. Two institutes operate as H…
Letters and debate
In a recently published article, Hever and Balogh ambitiously attempted to describe the “German approach to cost-effectiveness analysis in health care” (Hever – Balogh 2013). Unfortunately, parts of the text submitted by the authors contain inaccurate information by i) confusing the two separate “Methods” papers of IQWiG, ii) referring to the outdated aim of providing information for setting maximum reimbursable prices, and iii) erroneously stati…
Business (2 works) · Health Systems, Economic Evaluations, Quality of Life (2 works) · Healthcare cost, quality, practices (2 works) · Actuarial science (1 work) · Agency (philosophy (1 work) · Cost effectiveness (1 work) · Cost-effectiveness analysis (1 work) · Cost–benefit analysis (1 work) · Economic evaluation (1 work) · Economic growth (1 work)